Decision Maker Response
European Society of Endocrinology’s response
May 18, 2012 — Message sent on behalf of Professor Philippe Bouchard, ESE President
Thank you for writing to ESE, the European Hormone Society. We are well aware of the difficulties linked to thyroid hormone replacement therapy. Endocrinologists throughout the world are trying to improve such treatments. This has been emphasized by the recent euro american review by Biondi and Wartofsky in the JCEM. I understand that the journal Thyroid will also publish in June another analysis of this problem.
It is clear that we need to work more closely with persons treated. You can be sure that this is an area of concern for all of us. Research in collaboration with patients must continue, and even be reinforced.
We shall stay in touch on this matter.